News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Roche welcomes decision to fund Herceptin


Roche welcomes Government decision to fund Herceptin for 52 weeks

 

News release

10 December 2008

For immediate release

 

Roche Products (New Zealand) Limited says it has worked productively with the government, the Ministry of Health and PHARMAC in order to supply Herceptin to New Zealand women with early HER2 positive breast cancer.

Managing Director of Roche, Svend Petersen, says - “the company is very pleased that New Zealand women will now have the option to enjoy the same standard of care as that offered in 32 other countries around the world, including Australia”.

Mr Petersen says the weight of existing clinical evidence supports treating women with Herceptin for the full 52 week course. This regimen offers women with this aggressive form of breast cancer the best chance of living longer.

“By using Herceptin to treat early stage HER2 positive breast cancer we will save lives and significantly reduce the number of women who will require extensive and costly treatment for relapsed (advanced) disease”, Mr Petersen says.

“We have enough Herceptin to meet demand and are committed to supplying the Ministry of Health/District Health Boards immediately.” 

“Decades of research and investment in biotechnology are now producing major advances in the treatment of a wide variety of diseases. Whilst this innovation does come at a financial cost, medicines such as Herceptin can provide real value in return for the investment made.”

“We therefore welcome the Government’s commitment to increasing the investment into the New Zealand medicines budget.”

Ends

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Kakī: World’s Rarest Wading Bird Released In Mackenzie Basin

Conservation Minister Maggie Barry says the birds will add to the 60 released into the Tasman valley earlier this month, significantly boosting the wild population. More>>

ALSO:

IHC Tribute: Colin Meads

"While Colin is best known for rugby, to us he is one of a small number of distinguished IHC New Zealand Life Members recognised for their significant support for people with intellectual disabilities," says IHC Chief Executive Ralph Jones. More>>

ALSO:

Howard Davis Review: Tilting at Turbines - The Trip to Spain

Steve Coogan and Rob Brydon have now both broken the Big Fifty barrier, which seems to have brought a whole new level of angst to their midlife adventures ... More>>

Review: A Rose By Any Other Name Would Smell As Sweet

The Royal New Zealand Ballet has accepted the challenge of this heart-touching tragedy and largely succeeded. More>>

ALSO:

NZ's First Male IAAF Gold: Tom Walsh's Historic Shot Put Victory

Although feeling very sore but with a great feeling Tom Walsh took his place as number one on the victory dais to receive his much deserved gold medal. More>>

ALSO:

Scoop Review Of Books: Q&A: Hard To Find Books

"Unfortunately we are in crisis and this friendly dinosaur faces extinction… Our only hope is to try and raise funds to buy the building and restore it to its glory, either fully funded or with a viable deposit." More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland